Umaima Marvi, MD
Rheumatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Marvi’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A96953 · Current
Licensed to practise in California · since 2006 · expires 2028-02-29 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$12,859
Medicare paid this office $12,859 for 92 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 81 | $10,350 | $69 |
Who their Medicare patients are
92 Original Medicare patients in 2024. Average age 71 · Women 64% · Also on Medicaid 84% · Health risk score 2.04. Sicker patients than 9 in 10 peers; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 74% · Diabetes 36% · Chronic kidney disease 24% · Heart failure 21% · Coronary heart disease 17% · COPD 14% · Depression 14%.
The office billed $133,099, Medicare allowed $19,839 and paid $12,859; for 181 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 92 | 181 | 71 | 2.04 | $133,099 | $12,859 |
| 2023 | 91 | 192 | 70 | 1.92 | $141,473 | $13,779 |
| 2022 | 101 | 217 | 71 | 1.62 | $148,661 | $15,189 |
| 2021 | 142 | 292 | 71 | 1.79 | $162,545 | $18,466 |
| 2020 | 121 | 252 | 69 | 2.03 | $110,879 | $9,899 |
| 2019 | 162 | 352 | 68 | 1.73 | $225,481 | $22,193 |
| 2017 | 55 | 75 | 69 | 1.59 | $35,214 | $2,240 |
| 2016 | 127 | 283 | 68 | 1.43 | $108,636 | $13,583 |
| 2015 | 137 | 345 | 68 | 1.45 | $112,814 | $18,172 |
| 2014 | 126 | 289 | 66 | 1.42 | $65,239 | $11,413 |
| 2013 | 131 | 368 | 66 | 1.46 | $75,846 | $14,677 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 84 | $11,873 | $72 |
2022: 1 service
| Return visit (30+ min) | 88 | $12,290 | $74 |
2021: 5 services
| Return visit (30+ min) | 82 | $8,973 | $82 |
| Short return visit (20+ min) | 51 | $2,864 | $47 |
| Telephone medical discussion with physician, 11-20 minutes | 42 | $1,510 | $32 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,064 | $44 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $873 | $79 |
2020: 4 services
| Telephone medical discussion with physician, 11-20 minutes | 64 | $3,346 | $41 |
| Return visit (30+ min) | 64 | $3,190 | $41 |
| Telephone medical discussion with physician, 5-10 minutes | 26 | $737 | $24 |
| Short return visit (20+ min) | 17 | $682 | $40 |
2019: 4 services
| Return visit (30+ min) | 120 | $15,395 | $66 |
| New patient visit (45+ min) | 23 | $2,168 | $94 |
| Aspiration and/or injection of fluid from large joint | 28 | $1,449 | $47 |
| Short return visit (20+ min) | 19 | $967 | $44 |
2017: 2 services
| Return visit (30+ min) | 28 | $980 | $33 |
| Short return visit (20+ min) | 25 | $520 | $19 |
2016: 3 services
| Return visit (30+ min) | 94 | $8,382 | $53 |
| Short return visit (20+ min) | 54 | $2,394 | $39 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,186 | $37 |
2015: 3 services
| Return visit (30+ min) | 112 | $12,876 | $59 |
| Aspiration and/or injection of fluid from large joint | 31 | $1,976 | $40 |
| Short return visit (20+ min) | 25 | $948 | $34 |
2014: 4 services
| Short return visit (20+ min) | 100 | $6,955 | $34 |
| Aspiration and/or injection of fluid from large joint | 20 | $1,113 | $41 |
| Return visit (30+ min) | 15 | $769 | $51 |
| New patient visit (30+ min) | 11 | $418 | $38 |
2013: 3 services
| Short return visit (20+ min) | 92 | $7,825 | $39 |
| Aspiration and/or injection of fluid from large joint | 38 | $2,233 | $28 |
| New patient visit (30+ min) | 36 | $2,063 | $57 |
Medicaid work
$9,344 in 2024
Medicaid paid $9,344 for 2,472 billed services this clinician did in 2024, up to 71 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 577 | $9,344 |
| Pain severity quantified; pain present (COA) (ONC) | 35 | $0 |
| Medication list documented in medical record (COA) | 465 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 405 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 351 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 116 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 14 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 412 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 97 | $0 |
| 2024 | 2,472 | 9 | 71 | $9,344 |
| 2023 | 905 | 6 | 72 | $5,481 |
| 2022 | 482 | 4 | 53 | $3,507 |
| 2021 | 498 | 4 | 45 | $3,416 |
| 2020 | 214 | 1 | 44 | $1,966 |
| 2019 | 516 | 3 | 53 | $2,442 |
| 2018 | 405 | 4 | 36 | $1,932 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 644 | $5,481 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 61 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 50 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 34 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 104 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
2022
| Return visit (30+ min) | 432 | $3,243 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 16 | $141 |
| Measurement of C-reactive protein | 13 | $76 |
| Creatinine; blood | 21 | $46 |
2021
| Return visit (30+ min) | 321 | $2,552 |
| Short return visit (20+ min) | 149 | $674 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 16 | $141 |
| Sedimentation rate, erythrocyte; non-automated | 12 | $48 |
2020
| Return visit (30+ min) | 214 | $1,966 |
2019
| Return visit (30+ min) | 487 | $2,395 |
| Creatinine; blood | 13 | $47 |
| New patient visit (45+ min) | 16 | $0 |
2018
| Return visit (30+ min) | 340 | $1,532 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 28 | $239 |
| Sedimentation rate, erythrocyte; non-automated | 25 | $97 |
| Measurement of C-reactive protein | 12 | $64 |
Drugs they prescribed that Part D paid
$2,231,893
Pharmacies billed $2,231,893 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (25 of 1,485) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
1,042 generic and 443 brand-name prescriptions · $2,231,893 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira | 89 | $565,158 | $6,350 |
| Enbrel Sureclick | 75 | $508,740 | $6,783 |
| Xeljanz | 66 | $358,711 | $5,435 |
| Orencia | 42 | $222,221 | $5,291 |
| Enbrel | 19 | $129,617 | $6,822 |
See all 33 drugs
| Humira | 89 | $565,158 | $6,350 |
| Enbrel Sureclick | 75 | $508,740 | $6,783 |
| Xeljanz | 66 | $358,711 | $5,435 |
| Orencia | 42 | $222,221 | $5,291 |
| Enbrel | 19 | $129,617 | $6,822 |
| Orencia Clickject | 19 | $110,702 | $5,826 |
| Cosentyx Sensoready (2 Pens) | 13 | $91,911 | $7,070 |
| Benlysta | 12 | $55,440 | $4,620 |
| Kevzara | 12 | $49,775 | $4,148 |
| Actemra Actpen | 18 | $38,527 | $2,140 |
| Hydroxychloroquine Sulfate | 143 | $4,557 | $32 |
| Colchicine | 24 | $3,031 | $126 |
| Febuxostat | 26 | $2,602 | $100 |
| Methotrexate | 102 | $2,524 | $25 |
| Mycophenolate Mofetil | 21 | $1,949 | $93 |
| Azathioprine | 43 | $1,921 | $45 |
| Leflunomide | 34 | $1,846 | $54 |
| Prednisone | 126 | $1,191 | $9 |
| Sulfasalazine | 35 | $1,059 | $30 |
| Gabapentin | 80 | $818 | $10 |
| Fluocinonide | 17 | $481 | $28 |
| Diclofenac | 33 | $473 | $14 |
| Omeprazole | 42 | $325 | $8 |
| Allopurinol | 29 | $261 | $9 |
| Alendronate | 42 | $214 | $5 |
| Triamcinolone Acetonide | 13 | $171 | $13 |
| Hydrocodone-Acetaminophen | 14 | $127 | $9 |
| Amitriptyline | 12 | $119 | $10 |
| Meloxicam | 30 | $73 | $2 |
| Hydrocortisone | 18 | $67 | $4 |
| Baclofen | 17 | $44 | $3 |
| Amlodipine Besylate | 12 | $40 | $3 |
| Tramadol | 11 | $30 | $3 |
Year by year
| 2024 | 1,485 | 158 | 2% (25) | 30% | $2,231,893 |
| 2023 | 1,501 | 163 | 2% (33) | None | $2,568,917 |
| 2022 | 1,448 | 173 | 3% (46) | 30% | $1,989,565 |
| 2021 | 1,531 | 209 | 5% (71) | 26% | $1,771,320 |
| 2020 | 1,501 | 152 | 4% (66) | 26% | $1,394,723 |
| 2019 | 1,504 | 195 | 8% (116) | 31% | $1,428,859 |
| 2018 | 1,225 | 192 | 7% (80) | None | $1,104,773 |
| 2017 | 1,291 | 212 | 11% (136) | 33% | $1,186,191 |
| 2016 | 1,313 | 212 | 14% (185) | 28% | $804,813 |
| 2015 | 1,053 | 192 | 20% (211) | None | $431,315 |
| 2014 | 837 | 158 | 12% (97) | None | $221,431 |
| 2013 | 817 | 138 | 19% (151) | None | $189,734 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Humira | 83 | $563,645 | $6,791 |
| Enbrel Sureclick | 73 | $520,234 | $7,126 |
| Xeljanz | 51 | $380,414 | $7,459 |
| Orencia | 43 | $240,572 | $5,595 |
| Enbrel | 30 | $219,447 | $7,315 |
| Orencia Clickject | 18 | $108,572 | $6,032 |
| Benlysta | 18 | $81,983 | $4,555 |
| Actemra | 18 | $64,318 | $3,573 |
| Actemra Actpen | 26 | $63,362 | $2,437 |
| Kevzara | 11 | $43,312 | $3,937 |
| Mitigare | 22 | $12,659 | $575 |
| Febuxostat | 25 | $9,010 | $360 |
| Hydroxychloroquine Sulfate | 125 | $6,932 | $55 |
| Methotrexate | 92 | $6,653 | $72 |
| Colchicine | 31 | $4,314 | $139 |
| Leflunomide | 41 | $3,664 | $89 |
| Mycophenolate Mofetil | 19 | $1,996 | $105 |
| Prednisone | 120 | $1,946 | $16 |
| Gabapentin | 88 | $1,874 | $21 |
| Sulfasalazine | 31 | $1,663 | $54 |
| Diclofenac | 62 | $1,423 | $23 |
| Azathioprine | 30 | $1,300 | $43 |
| Omeprazole | 47 | $834 | $18 |
| Alendronate | 50 | $823 | $16 |
| Allopurinol | 31 | $800 | $26 |
| Hydrocodone-Acetaminophen | 19 | $705 | $37 |
| Tramadol | 13 | $270 | $21 |
| Nabumetone | 14 | $258 | $18 |
| Meloxicam | 28 | $224 | $8 |
| Valacyclovir | 11 | $213 | $19 |
| Pregabalin | 11 | $192 | $17 |
| Amlodipine Besylate | 15 | $174 | $12 |
| Triamcinolone Acetonide | 13 | $167 | $13 |
| Cyclobenzaprine | 13 | $153 | $12 |
| Baclofen | 14 | $147 | $10 |
2022: 30 drugs
| Enbrel Sureclick | 60 | $380,347 | $6,339 |
| Xeljanz | 63 | $362,122 | $5,748 |
| Humira | 62 | $341,418 | $5,507 |
| Enbrel | 38 | $249,906 | $6,576 |
| Orencia | 28 | $123,430 | $4,408 |
| Orencia Clickject | 18 | $97,596 | $5,422 |
| Actemra | 21 | $78,916 | $3,758 |
| Actemra Actpen | 19 | $45,056 | $2,371 |
| Kevzara | 11 | $41,284 | $3,753 |
| Mitigare | 28 | $13,464 | $481 |
| Febuxostat | 19 | $9,096 | $479 |
| Hydroxychloroquine Sulfate | 159 | $7,437 | $47 |
| Methotrexate | 96 | $6,954 | $72 |
| Colchicine | 20 | $5,069 | $253 |
| Leflunomide | 34 | $3,771 | $111 |
| Azathioprine | 16 | $1,942 | $121 |
| Sulfasalazine | 33 | $1,794 | $54 |
| Prednisone | 119 | $1,553 | $13 |
| Diclofenac | 66 | $1,452 | $22 |
| Gabapentin | 50 | $1,057 | $21 |
| Allopurinol | 37 | $791 | $21 |
| Alendronate | 53 | $626 | $12 |
| Omeprazole | 43 | $524 | $12 |
| Hydrocodone-Acetaminophen | 28 | $405 | $14 |
| Triamcinolone Acetonide | 27 | $307 | $11 |
| Cyproheptadine | 11 | $278 | $25 |
| Nabumetone | 17 | $207 | $12 |
| Meloxicam | 38 | $184 | $5 |
| Tramadol | 18 | $143 | $8 |
| Cyclobenzaprine | 11 | $74 | $7 |
2021: 32 drugs
| Xeljanz | 71 | $340,481 | $4,796 |
| Enbrel | 57 | $326,600 | $5,730 |
| Enbrel Sureclick | 57 | $318,056 | $5,580 |
| Humira | 58 | $315,194 | $5,434 |
| Orencia | 21 | $82,622 | $3,934 |
| Actemra | 16 | $78,583 | $4,911 |
| Orencia Clickject | 14 | $72,124 | $5,152 |
| Kevzara | 11 | $36,988 | $3,363 |
| Methotrexate | 105 | $8,277 | $79 |
| Hydroxychloroquine Sulfate | 187 | $7,926 | $42 |
| Leflunomide | 44 | $5,640 | $128 |
| Mitigare | 17 | $5,557 | $327 |
| Colchicine | 20 | $4,446 | $222 |
| Febuxostat | 16 | $3,051 | $191 |
| Sulfasalazine | 50 | $2,667 | $53 |
| Diclofenac | 68 | $1,833 | $27 |
| Prednisone | 120 | $1,794 | $15 |
| Hydrocodone-Acetaminophen | 51 | $1,656 | $32 |
| Gabapentin | 74 | $1,423 | $19 |
| Pilocarpine | 12 | $1,303 | $109 |
| Azathioprine | 27 | $987 | $37 |
| Mycophenolate Mofetil | 16 | $904 | $56 |
| Omeprazole | 49 | $464 | $9 |
| Nabumetone | 22 | $441 | $20 |
| Allopurinol | 25 | $428 | $17 |
| Alendronate | 37 | $230 | $6 |
| Triamcinolone Acetonide | 24 | $209 | $9 |
| Meloxicam | 36 | $171 | $5 |
| Tramadol | 14 | $133 | $10 |
| Cyclobenzaprine | 11 | $104 | $9 |
| Ibuprofen | 13 | $89 | $7 |
| Naproxen | 11 | $67 | $6 |
2020: 28 drugs
| Enbrel Sureclick | 67 | $340,435 | $5,081 |
| Enbrel | 61 | $332,279 | $5,447 |
| Humira | 42 | $219,317 | $5,222 |
| Orencia | 31 | $122,050 | $3,937 |
| Xeljanz | 25 | $112,641 | $4,506 |
| Kevzara | 11 | $37,163 | $3,378 |
| Actemra Actpen | 15 | $33,374 | $2,225 |
| Hydroxychloroquine Sulfate | 206 | $9,710 | $47 |
| Leflunomide | 60 | $7,826 | $130 |
| Methotrexate | 109 | $5,993 | $55 |
| Mitigare | 11 | $5,281 | $480 |
| Febuxostat | 17 | $4,303 | $253 |
| Colchicine | 11 | $3,454 | $314 |
| Sulfasalazine | 61 | $2,278 | $37 |
| Diclofenac | 80 | $1,957 | $24 |
| Mycophenolate Mofetil | 20 | $1,839 | $92 |
| Prednisone | 123 | $1,603 | $13 |
| Hydrocodone-Acetaminophen | 37 | $1,239 | $33 |
| Gabapentin | 84 | $957 | $11 |
| Azathioprine | 19 | $865 | $46 |
| Nyamyc | 15 | $526 | $35 |
| Omeprazole | 49 | $361 | $7 |
| Nabumetone | 19 | $333 | $18 |
| Alendronate | 35 | $324 | $9 |
| Acetaminophen-Codeine | 18 | $240 | $13 |
| Naproxen | 22 | $197 | $9 |
| Meloxicam | 39 | $172 | $4 |
| Tramadol | 11 | $117 | $11 |
2019: 32 drugs
| Enbrel Sureclick | 69 | $364,437 | $5,282 |
| Enbrel | 55 | $288,989 | $5,254 |
| Humira | 38 | $189,651 | $4,991 |
| Orencia | 34 | $144,171 | $4,240 |
| Xeljanz | 30 | $134,137 | $4,471 |
| Humira | 19 | $101,783 | $5,357 |
| Actemra | 11 | $42,954 | $3,905 |
| Hydroxychloroquine Sulfate | 138 | $17,773 | $129 |
| Leflunomide | 42 | $11,448 | $273 |
| Colchicine | 28 | $8,804 | $314 |
| Uloric | 13 | $7,776 | $598 |
| Methotrexate | 129 | $7,072 | $55 |
| Colcrys | 20 | $6,796 | $340 |
| Xarelto | 11 | $4,857 | $442 |
| Sulfasalazine | 43 | $2,018 | $47 |
| Hydrocodone-Acetaminophen | 69 | $1,839 | $27 |
| Prednisone | 119 | $1,806 | $15 |
| Mycophenolate Mofetil | 15 | $1,284 | $86 |
| Azathioprine | 23 | $1,159 | $50 |
| Diclofenac | 27 | $867 | $32 |
| Gabapentin | 93 | $729 | $8 |
| Voltaren | 21 | $728 | $35 |
| Omeprazole | 60 | $555 | $9 |
| Allopurinol | 14 | $536 | $38 |
| Alendronate | 44 | $465 | $11 |
| Nabumetone | 22 | $415 | $19 |
| Baclofen | 26 | $268 | $10 |
| Meloxicam | 52 | $265 | $5 |
| Tramadol | 31 | $250 | $8 |
| Acetaminophen-Codeine | 15 | $196 | $13 |
| Naproxen | 19 | $143 | $8 |
| Cyclobenzaprine | 13 | $40 | $3 |
2018: 32 drugs
| Humira | 52 | $249,326 | $4,795 |
| Enbrel Sureclick | 44 | $220,306 | $5,007 |
| Orencia | 34 | $136,230 | $4,007 |
| Enbrel | 25 | $125,817 | $5,033 |
| Xeljanz | 26 | $104,568 | $4,022 |
| Actemra | 19 | $72,776 | $3,830 |
| Humira | 13 | $61,592 | $4,738 |
| Hydroxychloroquine Sulfate | 106 | $13,889 | $131 |
| Leflunomide | 36 | $9,794 | $272 |
| Uloric | 11 | $9,213 | $838 |
| Colcrys | 19 | $9,082 | $478 |
| Methotrexate | 109 | $6,691 | $61 |
| Xarelto | 13 | $3,744 | $288 |
| Sulfasalazine | 48 | $2,141 | $45 |
| Voltaren | 33 | $1,365 | $41 |
| Hydrocodone-Acetaminophen | 49 | $1,308 | $27 |
| Mycophenolate Mofetil | 13 | $1,166 | $90 |
| Prednisone | 94 | $951 | $10 |
| Gabapentin | 59 | $669 | $11 |
| Diclofenac | 14 | $505 | $36 |
| Nabumetone | 28 | $483 | $17 |
| Azathioprine | 11 | $435 | $40 |
| Allopurinol | 16 | $429 | $27 |
| Omeprazole | 55 | $401 | $7 |
| Alendronate | 32 | $290 | $9 |
| Meloxicam | 47 | $243 | $5 |
| Naproxen | 26 | $227 | $9 |
| Acetaminophen-Codeine | 13 | $190 | $15 |
| Cyclobenzaprine | 12 | $167 | $14 |
| Baclofen | 15 | $138 | $9 |
| Tramadol | 14 | $89 | $6 |
| Ibuprofen | 14 | $74 | $5 |
2017: 30 drugs
| Enbrel Sureclick | 61 | $327,188 | $5,364 |
| Enbrel | 49 | $230,207 | $4,698 |
| Humira | 49 | $213,069 | $4,348 |
| Orencia | 28 | $106,240 | $3,794 |
| Humira | 21 | $91,320 | $4,349 |
| Simponi | 13 | $50,371 | $3,875 |
| Hydroxychloroquine Sulfate | 79 | $10,820 | $137 |
| Uloric | 19 | $10,754 | $566 |
| Leflunomide | 31 | $9,190 | $296 |
| Colcrys | 22 | $7,003 | $318 |
| Methotrexate | 116 | $6,672 | $58 |
| Diclofenac | 12 | $6,263 | $522 |
| Lidocaine | 17 | $3,987 | $235 |
| Colchicine | 18 | $3,151 | $175 |
| Sulfasalazine | 57 | $2,235 | $39 |
| Voltaren | 39 | $2,189 | $56 |
| Hydrocodone-Acetaminophen | 86 | $1,655 | $19 |
| Mycophenolate Mofetil | 20 | $1,136 | $57 |
| Prednisone | 103 | $1,051 | $10 |
| Gabapentin | 52 | $682 | $13 |
| Nabumetone | 30 | $520 | $17 |
| Omeprazole | 40 | $467 | $12 |
| Acetaminophen-Codeine | 27 | $440 | $16 |
| Baclofen | 24 | $264 | $11 |
| Ibuprofen | 30 | $224 | $7 |
| Meloxicam | 32 | $216 | $7 |
| Alendronate | 26 | $169 | $7 |
| Naproxen | 19 | $167 | $9 |
| Tramadol | 22 | $147 | $7 |
| Amlodipine Besylate | 18 | $127 | $7 |
2016: 27 drugs
| Enbrel | 93 | $380,293 | $4,089 |
| Humira | 24 | $103,803 | $4,325 |
| Orencia | 20 | $89,027 | $4,451 |
| Humira | 19 | $74,224 | $3,907 |
| Kineret | 12 | $22,797 | $1,900 |
| Uloric | 21 | $13,976 | $666 |
| Leflunomide | 49 | $13,198 | $269 |
| Hydroxychloroquine Sulfate | 87 | $12,759 | $147 |
| Methotrexate | 102 | $6,075 | $60 |
| Colchicine | 34 | $5,713 | $168 |
| Lidocaine | 20 | $5,385 | $269 |
| Hydrocodone-Acetaminophen | 122 | $3,387 | $28 |
| Sulfasalazine | 45 | $1,675 | $37 |
| Voltaren | 24 | $1,571 | $65 |
| Diclofenac | 11 | $1,292 | $117 |
| Prednisone | 99 | $1,187 | $12 |
| Gabapentin | 54 | $1,110 | $21 |
| Nabumetone | 25 | $595 | $24 |
| Acetaminophen-Codeine | 21 | $475 | $23 |
| Naproxen | 47 | $471 | $10 |
| Baclofen | 42 | $468 | $11 |
| Omeprazole | 73 | $433 | $6 |
| Ibuprofen | 20 | $242 | $12 |
| Tramadol | 41 | $217 | $5 |
| Allopurinol | 11 | $182 | $17 |
| Cyclobenzaprine | 20 | $114 | $6 |
| Alendronate | 14 | $110 | $8 |
2015: 25 drugs
| Enbrel | 44 | $145,827 | $3,314 |
| Humira | 21 | $74,996 | $3,571 |
| Orencia | 19 | $73,306 | $3,858 |
| Forteo | 11 | $21,494 | $1,954 |
| Hydroxychloroquine Sulfate | 68 | $13,116 | $193 |
| Leflunomide | 35 | $7,508 | $215 |
| Methotrexate | 68 | $4,946 | $73 |
| Hydrocodone-Acetaminophen | 130 | $3,952 | $30 |
| Gabapentin | 61 | $1,521 | $25 |
| Diclofenac | 11 | $1,137 | $103 |
| Voltaren | 24 | $1,001 | $42 |
| Sulfasalazine | 23 | $816 | $35 |
| Nabumetone | 30 | $760 | $25 |
| Prednisone | 56 | $675 | $12 |
| Acetaminophen-Codeine | 39 | $669 | $17 |
| Azathioprine | 11 | $622 | $57 |
| Allopurinol | 16 | $404 | $25 |
| Ibuprofen | 30 | $381 | $13 |
| Omeprazole | 43 | $345 | $8 |
| Cyclobenzaprine | 18 | $303 | $17 |
| Baclofen | 20 | $287 | $14 |
| Tramadol | 31 | $242 | $8 |
| Amitriptyline | 20 | $222 | $11 |
| Naproxen | 32 | $215 | $7 |
| Alendronate | 12 | $94 | $8 |
2014: 23 drugs
| Humira | 40 | $106,172 | $2,654 |
| Enbrel | 19 | $50,427 | $2,654 |
| Methotrexate | 44 | $3,961 | $90 |
| Colcrys | 11 | $3,232 | $294 |
| Hydroxychloroquine Sulfate | 49 | $1,640 | $33 |
| Leflunomide | 19 | $1,574 | $83 |
| Hydrocodone-Acetaminophen | 58 | $1,329 | $23 |
| Sulfasalazine | 28 | $1,063 | $38 |
| Gabapentin | 48 | $968 | $20 |
| Omeprazole | 43 | $923 | $21 |
| Prednisone | 56 | $788 | $14 |
| Nabumetone | 37 | $788 | $21 |
| Baclofen | 28 | $512 | $18 |
| Voltaren | 12 | $489 | $41 |
| Ibuprofen | 37 | $482 | $13 |
| Diclofenac | 12 | $443 | $37 |
| Naproxen | 30 | $329 | $11 |
| Acetaminophen-Codeine | 24 | $256 | $11 |
| Alendronate | 16 | $216 | $13 |
| Allopurinol | 25 | $195 | $8 |
| Cyclobenzaprine | 13 | $82 | $6 |
| Tramadol | 14 | $81 | $6 |
| Amlodipine Besylate | 16 | $76 | $5 |
2013: 21 drugs
| Humira | 29 | $81,134 | $2,798 |
| Enbrel | 12 | $50,423 | $4,202 |
| Colcrys | 15 | $3,771 | $251 |
| Methotrexate | 28 | $2,949 | $105 |
| Sulfasalazine | 49 | $1,847 | $38 |
| Hydroxychloroquine Sulfate | 62 | $1,801 | $29 |
| Hydrocodone-Acetaminophen | 100 | $1,790 | $18 |
| Leflunomide | 15 | $1,620 | $108 |
| Omeprazole | 44 | $1,327 | $30 |
| Gabapentin | 26 | $997 | $38 |
| Diclofenac | 21 | $926 | $44 |
| Prednisone | 70 | $637 | $9 |
| Nabumetone | 27 | $606 | $22 |
| Alendronate | 18 | $337 | $19 |
| Acetaminophen-Codeine | 30 | $287 | $10 |
| Ibuprofen | 25 | $176 | $7 |
| Naproxen | 18 | $161 | $9 |
| Baclofen | 18 | $154 | $9 |
| Tramadol | 17 | $138 | $8 |
| Allopurinol | 14 | $79 | $6 |
| Trazodone | 11 | $59 | $5 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1316129083
- Licence
- CA A96953California A96953: Current · expires 2028-02-29
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2005
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, Internal Medicine Dept, San Jose, CA, 95128
- NPI first listed
- 2007-12-04
- NPI last updated
- 2007-12-04
This is when the NPI record was last certified, not a medical board exam.